LicianPro

KYTX holders · CITADEL ADVISORS LLC 13F · KYTX stock

CITADEL ADVISORS LLC Kyverna Therapeutics, Inc. Common Stock (KYTX) 13F holding

CITADEL ADVISORS LLC reported 58,126 KYTX shares valued at $501.6K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest KYTX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the KYTX holders table.

KYTX reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-3158,126$501.6KCOM
2025-12-31275,446$2.6MCOM
2025-09-3017,666$106.0KCOM
2025-06-30325,389$998.9KCOM

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.